-+ 0.00%
-+ 0.00%
-+ 0.00%

SILO PHARMA - DATA TO SUPPORT PLANNED FDA TYPE C MEETING REQUEST FOR IND STRATEGY AND PHASE 1 DESIGN

Reuters·06/29/2026 20:16:20

Please log in to view news